Eli Lilly Enters USD 1.12 Billion Gene-Editing Partnership with Seamless Therapeutics
Eli Lilly and Company has entered into a strategic collaboration worth up to USD 1.12 billion with private gene-editing company Seamless Therapeutics to develop next-generation therapies for hearing loss. The agreement strengthens Lilly’s push into genetic medicines and expands its pipeline beyond its core diabetes and obesity treatments.
Engineering | 29/01/2026 | By Darshana | 190
India - EU FTA Must Ensure Level Playing Field for Medical Device Makers: AiMeD
The proposed India–European Union Free Trade Agreement (FTA) has the potential to reshape India’s pharmaceutical and medical devices landscape, but industry leaders caution that its success will depend on how fairly it balances market access, regulatory alignment and domestic manufacturing interests.
Engineering | 28/01/2026 | By Darshana | 244
Alphatec Signs Strategic US Commercial Deal with Theradaptive, Backs Series B Expansion
Alphatec Holdings Inc (ATEC), a spine-focused medical technology company, and Theradaptive Inc, a clinical-stage regenerative medicine innovator, have entered into a definitive strategic partnership to advance next-generation biologic solutions for spine surgery.
Engineering | 14/01/2026 | By Darshana | 324
Bayer Partners with Souffle Therapeutics to Develop Heart-Targeted siRNA Therapy
Bayer and Soufflé Therapeutics, a biotechnology company focused on developing cell-selective genetic medicines, have entered into a strategic collaboration and global licensing agreement to advance a heart-targeted small interfering RNA (siRNA) therapy for a rare form of dilated cardiomyopathy.
Engineering | 09/01/2026 | By Darshana | 500
Agilent Advances Sustainable Science with New India Refurbishment Centre
Agilent Technologies has inaugurated a new refurbishment centre in India, reinforcing its commitment to sustainable science and affordable innovation while enhancing customer engagement through an integrated, green-certified facility that also houses a dedicated education centre.
Engineering | 18/12/2025 | By News Bureau | 250
AlidaBio Launches EpiPlex Duo-Mod for Dual m6A-Inosine Mapping with RNA Expression Profiling
AlidaBio has launched the EpiPlex Duo-Mod Service, offering simultaneous m6A and inosine mapping with integrated gene expression profiling, enabling researchers to compare modification patterns and transcriptional changes from a single RNA input.
Engineering | 06/12/2025 | By Dineshwori | 149
Continuous Tableting Breakthrough: GEA and Hovione Introduce ConsiGma CDC Flex System
GEA and Hovione have expanded their long-standing partnership with the launch of the ConsiGma CDC Flex system — a next-generation continuous direct compression (CDC) platform designed to deliver greater flexibility, simplicity and cost-efficiency in the development and production of oral solid dosage forms.
Engineering | 04/12/2025 | By Dineshwori | 181
TQ Therapeutics GmbH Enters into Technology Access Agreement with Kytopen
Kytopen has strengthened its European footprint with a new partnership granting TQ Therapeutics on-site access to its non-viral Flowfect Tx cellular engineering platform. The collaboration will support integration of the technology into TQ’s CELLfinity platform.
Engineering | 04/12/2025 | By Dineshwori | 187
Elekta Launches Evo Linear Accelerator in India
Elekta has introduced its latest linear accelerator (linac), Evo, to the Indian market, expanding its global rollout after introductions in Europe and other regions.
Engineering | 01/12/2025 | By Dineshwori | 422
Granules launches peptide and particle-engineering centres at IIT Hyderabad
Granules India Limited has inaugurated two new Centres of Excellence at IIT Hyderabad’s Technology Research Park, strengthening its capabilities in advanced pharmaceutical research and development.
Engineering | 01/12/2025 | By Darshana | 208
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy